Izumo, Japan

Hideki Okunishi

This inventor holds 2 USPTO granted patents. Top assignees: Kyoto Pharmaceutical Industries, Ltd., Suntory Limited. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Okunishi. Retrieved from https://idiyas.com/inventor/hideki-okunishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hideki Okunishi

Introduction

Hideki Okunishi is a notable inventor based in Izumo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs targeting fibrosis and rheumatic conditions. With a total of 2 patents, his work has garnered attention in the medical community.

Latest Patents

Okunishi's latest patents include innovative formulations for preventive or therapeutic drugs for fibrosis, which utilize chymase inhibitors as the active ingredient. Additionally, he has developed an antirheumatic agent that aims to provide relief for patients suffering from rheumatic diseases.

Career Highlights

Throughout his career, Okunishi has worked with prominent companies such as Suntory Limited and Kyoto Pharmaceutical Industries, Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Okunishi has collaborated with esteemed colleagues, including Harukazu Fukami and Eiichi Kakizoe. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Hideki Okunishi's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…